You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Prediction and Measurement of the Carbon Build-Up in Film-Cooled Rocket Engines

    SBC: SIERRA ENGINEERING, INC.            Topic: AF15AT21

    ABSTRACT: Sierra Engineering Inc. (Sierra) believes that existing chemical kinetic models can be efficiently incorporated into commercial CFD codes to predict the mixing, pyrolysis, soot formation and carbon deposition within film cooled rocket engines. During this Phase I STTR effort we will demonstrate that this analysis capability is practical and that we can generate appropriate model validati ...

    STTR Phase I 2015 Department of DefenseAir Force
  2. Compact Passive Millimeter Wave Sensor for GPS-denied Navigation

    SBC: PHASE SENSITIVE INNOVATIONS INC            Topic: AF15AT26

    ABSTRACT: Under the proposed effort, PSI will leverage a novel pmmW imaging technology developed under a prior Navy program to realize the low size, weight, and power sensors required for UAV implementation. This technology is based on an optical upconverted distributed aperture technology that can make use of the full aperture of the aircraft thereby maximizing achievable resolution. This sensor ...

    STTR Phase I 2015 Department of DefenseAir Force
  3. Optimization of an integrin enhancing molecule for the treatment of Duchenne muscular dystrophy

    SBC: STRYKAGEN CORPORATION            Topic: NIAMS

    DESCRIPTION provided by applicant Duchenne muscular dystrophy is caused by mutations in the dystrophin gene resulting in the loss of the dystrophin glycoprotein complex in skeletal muscle Loss of dystrophin results in reduced sarcolemmal integrity progressive muscle damage and compromised muscle function There is currently no cure and limited treatment options for DMD and all affected child ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  4. STTR Phase II: Micromachined components for wireless applications

    SBC: LASERLITH CORP.            Topic: ES

    The broader impact/commercialization potential of this project include tunable blocks that would allow a range of spectrally- and spatially-agile devices. These may include high-gain directional antennas that can improve performance while reducing power consumption. The fundamental MEMS varactor technology also offers solutions for critical efficiency and linearity problems as wireless devices emp ...

    STTR Phase II 2014 National Science Foundation
  5. STTR Phase I: Surgical Glove with Shear Thickening Fluid Textile Composites for Protection Against Needlestick Injuries

    SBC: STF TECHNOLOGIES LLC            Topic: BC

    This Small Business Technology Transfer Research (STTR) Phase I project will demonstrate the technical and commercial feasibility of a puncture resistant surgical glove having areas reinforced by flexible, needle resistant nanocomposite materials made from knit textiles intercalated with shear thickening fluids (STF). STF treated textiles are a class of smart material that respond differently base ...

    STTR Phase I 2014 National Science Foundation
  6. STTR Phase I: Integration of carbohydrate and gaseous fermentations for maximum C4 chemical yield

    SBC: ELCRITON, INC            Topic: BC

    This Small Business Technology Transfer Research Phase I project aims to enhance fermentation yield of four carbon (C4) chemicals by instating mixotrophic fermentation. In order to realize the most cost effective fermentation for commodity chemical and biofuel production, the process should achieve maximum conversion of feedstock. In carbohydrate fermentations, CO2 and H2 are commonly evolved, whi ...

    STTR Phase I 2014 National Science Foundation
  7. STTR Phase I: Novel Cathode Materials for Flexible Batteries

    SBC: SPECTRUM MAGNETICS LLC            Topic: CT

    The broader impact/commercial potential of this project is the introduction of new generation energy storage devices that are mechanically strong, highly flexible, and high energy density. The proposed novel flexible cathode electrode technology holds the key to commercialize high performance flexible batteries. If successful, the proposed research program will generate critical knowledge for fabr ...

    STTR Phase I 2014 National Science Foundation
  8. STTR Phase I: Novel Multifunctional, Bio-Based Coupling Agents for Wood Plastic Composites

    SBC: RENUVIX LLC            Topic: CT

    The broader impact/commercial potential of this project involves a significant enhancement in the properties of wood polymer composites (WPCs) by the commercialization of a highly effective bio-based coupling agent made from renewable sources such as plant oils instead of petroleum. By significantly enhancing the properties of WPCs, substantial benefit to society will result by providing new appli ...

    STTR Phase I 2014 National Science Foundation
  9. STTR Phase I: Novel Ionization Process for Materials Characterization using Mass Spectrometry

    SBC: MSTM LLC            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project will be to provide a new and improved molecular characterization tool to be used with mass spectrometers for applications in biotechnology, pharmaceutical, forensic, clinical, environmental, food, and material sciences. Disruptive discoveries of new ionization technology for mass spectrometry ...

    STTR Phase I 2014 National Science Foundation
  10. Galectin 1: A novel small protein therapy for Duchenne muscular dystrophy

    SBC: STRYKAGEN CORPORATION            Topic: NIAMS

    DESCRIPTION provided by applicant Duchenne Muscular Dystrophy DMD is a fatal muscle disease affecting in every male births DMD results from mutations in the gene encoding the dystrophin a kDa scaffolding protein responsible for providing a mechanical link between the muscle fiber actin cytoskeleton and a transmembrane protein complex called the dystrophin associated glycoprotein ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government